Table 4.
Stroke Risk | Bleeding Risk | AHA Aggressive | AHA Conservative | Casciano | CHEST | ESC | LaHaye |
---|---|---|---|---|---|---|---|
Low (CHA2DS2-VASc score = 0) | Low (HAS-BLED score = 0) | 627 (38.51%) | 627 (38.51%) | 627 (38.51%) | 627 (38.51%) | 627 (38.51%) | 627 (38.51%) |
Medium (HAS-BLED score = 1 or 2) | 176 (40.09%) | 176 (40.09%) | 176 (40.09%) | 176 (40.09%) | 176 (40.09%) | 176 (40.09%) | |
High (HAS-BLED score ≥ 3) | 1 (16.67%) | 1 (16.67%) | 1 (16.67%) | 1 (16.67%) | 1 (16.67%) | 1 (16.67%) | |
Sub-total | 804 (38.78%) | 804 (38.78%) | 804 (38.78%) | 804 (38.78%) | 804 (38.78%) | 804 (38.78%) | |
Medium (CHA2DS2-VASc score = 1 | Low (HAS-BLED score = 0) | ARO | 403 (38.64%) | 262 (30.82%) | 261 (30.81%) | ARO | 403 (38.64%) |
Medium (HAS-BLED score = 1 or 2) | ARO | 1041 (49.74%) | 331 (45.84%) | 264 (44.90%) | ARO | 1041 (49.74%) | |
High (HAS-BLED score ≥ 3) | ARO | 34 (55.74%) | 23 (54.76%) | 4 (100.00%) | 34 (55.74%) | 34 (55.74%) | |
Sub-total | ARO | 1478 (46.23%) | 616 (38.17%) | 529 (36.76%) | 34 (55.73%) | 1478 (46.23%) | |
High (CHA2DS2-VASc score ≥ 2) | Low (HAS-BLED score = 0) | ARO | ARO | 25 (36.76%) | 19 (31.15%) | ARO | ARO |
Medium (HAS-BLED score = 1 or 2) | ARO | ARO | 486 (48.07%) | 163 (45.03%) | ARO | 3167 (55.29%) | |
High (HAS-BLED score ≥ 3) | ARO | ARO | 293 (48.83%) | 9 (60.00%) | ARO | 1044 (55.68%) | |
Sub-total | ARO | ARO | 804 (47.88%) | 191 (43.61%) | ARO | 4211 (55.38%) | |
Overall | Total | 804 (38.78%) | 2282 (43.30%) | 2224 (41.45%) | 1564 (39.59%) | 838 (39.27%) | 6493 (50.43%) |
Data is presented as n (%) of patients who are not consistent with the non- OAC treatment recommendation by each decision aid. ARO: Always recommends OAC. AHA Aggressive: AHA guidelines (assuming that guideline recommends OAC at CHA2DS2-VASc = 1), AHA Conservative: AHA guidelines (assuming that guideline recommends non-OAC at CHA2DS2-VASc = 1), Casciano: Casciano tool, CHEST: CHEST guidelines, ESC: ESC guidelines, LaHaye: LaHaye tool.